Avita Medical Limited is a biotechnology company which develops and distributes tissue-engineered cellular products for skin replacement. The Company's products include CellSpray and ReCell, which are used for the treatment of burns and other skin injuries, previous scarring, chronic wounds and cosmetic procedures.

AVITA Medical to Announce Third Quarter 2024 Results

Notice under section 708A(5)(e) of the Corporations Act

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Avita Medical (AVH AU)

AVITA Medical to Announce Third Quarter 2024 Results

Notice under section 708A(5)(e) of the Corporations Act

Notification regarding unquoted securities - AVH

Statement of CDIs on issue - AVH

Notification of cessation of securities - AVH

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)